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Abstract
To determine potential links between the clinical isolate to animal products and their geographic origin, we genotyped
(MLVA-8, MVLA-15, and canSNP analysis) 80 environmental and 12 clinical isolates and 2 clinical specimens from five cases
of anthrax (California in 1976 [n = 1], New York in 2006 [n = 1], Connecticut in 2007 [n = 2], and New Hampshire in
2009[n = 1]) resulting from recreational handling of animal products. For the California case, four clinical isolates were
identified as MLVA-8 genotype (GT) 76 and in the canSNP A.Br.Vollum lineage, which is consistent with the Pakistani origin
of the yarn. Twenty eight of the California isolates were in the A.Br.Vollum canSNP lineage and one isolate was in the A.Br.
003/004 canSNP sub-group. All 52 isolates and both clinical specimens related to the New York and Connecticut cases were
MLVA-8 GT 1. The animal products associated with the NY and CT cases were believed to originate from West Africa, but no
isolates from this region are available to be genotyped for comparison. All isolates associated with the New Hampshire case
were identical and had a new genotype (GT 149). Isolates from the NY, CT and NH cases diverge from the established
canSNP phylogeny near the base of the A.Br.011/009. This report illustrates the power of the current genotyping methods
and the dramatically different epidemiological conditions that can lead to infections (i.e., contamination by a single
genotype versus widespread contamination of numerous genotypes). These cases illustrate the need to acquire and
genotype global isolates so that accurate assignments can be made about isolate origins.
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Introduction
Bacillus anthracis is the etiologic agent of anthrax, a zoonotic
disease which historically affected people in the United States who
worked at textile mills or had other contact with contaminated
animal products. In the USA, industrial processing of animal
products accounted for the majority of human anthrax cases
(n = 153) from 1955–1999 [1]. However, with improvements in
industrial hygiene and the implementation of other practices (such
as improved ventilation, vaccination of at-risk employees,
decreased use of imported animal products), industrial cases of
anthrax began to decline.
Reports of anthrax cases related to handling of animal
products in a non-industrial setting are rare in the USA. In
1974, a cutaneous anthrax case was reported in a woman who
bought drums made from goat hides in Haiti [2]. Prior to the
2001 bioterrorism-associated anthrax outbreak, the last fatal case
of inhalation anthrax in the USA occurred in a self-employed, 32-
year-old male home weaver in California in 1976 [3]. In follow-
up investigations, the source of B. anthracis was determined to be
contaminated hand-spun yarn consisting of various types of
animal fibers (camel, goat, and sheep) imported from Pakistan
[3,4].
Recently, two inhalation and two cutaneous cases of anthrax
were related to drum-making using imported goat hides. In 2006,
two unrelated inhalation anthrax cases were reported in New York
City and Scotland [1,5]. In the New York City case, the patient,
who recovered, made traditional African drums from processed
hard-dried goat hides imported from West Africa. The case from
Scotland also involved a drum-maker and was fatal. Additionally,
in 2007, two cases of cutaneous anthrax were reported in a
Connecticut drum-maker and his son [6]. This drum-maker also
made West African drums using unprocessed hides. Lastly, in
2009, a gastrointestinal anthrax case was reported in a female
drummer from New Hampshire [7]. In this case, the drummer did
not make drums but attended a drumming event held in a
community building where drums of various animal hides were
played.
While B. anthracis has very little genetic variation, successful
molecular subtyping methods have been developed within the last
decade to examine phylogenetic relationships among isolates and
as a molecular epidemiology tool to investigate anthrax cases. The
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original multiple-locus variable-number tandem repeats analysis
system (MLVA) targeted eight loci (six chromosomally-located loci
and one on each of the two virulence plasmids, pXO1 and pXO2)
[8]. This method has been used to identify 89 B. anthracis genotypes
(GTs), to study anthrax ecology, and to genotype isolates during
the 2001 bioterrorism-associated anthrax outbreak. The MLVA-
15 scheme includes seven additional loci and allows for increased
differentiation of isolates [9]. Canonical single nucleotide poly-
morphism (canSNPs) analysis has been used to identify major
clonal lineages within B. anthracis [9]. CanSNP analysis, in concert
with MLVA-15, was used to subtype over 1000 isolates from 42
countries and subdivided the three major B. anthracis lineages into
12 clonal sub-lineages or sub-groups and 221 MLVA-15 genotypes
[9].
In this report, we describe the molecular epidemiology of the
anthrax cases linked to the recreational use of animal products
occurring in the USA which includes the California and New York
City inhalation anthrax cases, the two cutaneous cases from
Connecticut, and the gastrointestinal case in New Hampshire. In
all five cases, epidemiologic and environmental investigations were
carried out to determine the source of exposure. For the 2006 and
2007 cases, law enforcement authorities were also involved to rule
out any potential criminal activity. Numerous samples were
collected from each patient’s home, work space, or other
associated facilities as part of the respective investigations.
Culturing of the samples resulted in the recovery of many B.
anthracis isolates. We utilized both MLVA-8 and MLVA-15, in
addition to SNP analysis, to subtype both clinical and environ-
mental isolates to determine 1) the genotype and canSNP lineage
of the infectious isolate, 2) the genotypes of strains contaminating
the patient’s residence or work space, 3) the potential link between
the source of the infectious isolate to animal products (goat hide,
yarn, etc.) and 4) if the origin of the isolates as predicted by
genotype is consistent with what is known about the origin of the
animal products.
Results
In this report, we analyzed 94 isolates and specimens by
MLVA-8, MLVA-15 and canSNP analysis from five inhalation
and cutaneous anthrax cases from a weaver (1976), three
individuals associated with drum-making (2006, 2007), and a
drummer (2009).
1976 California inhalation case
The six chromosomal loci of the MLVA-8 scheme were
detected in all 29 isolates (Table 1). However, amplification of
the pXO1 and/or the pXO2 loci failed for 19 (5 clinical, 14
environmental) of the isolates suggesting they lacked one or both
virulence plasmids. This was further supported by additional
plasmid specific PCR assays performed which also yielded
negative results (data not shown). Seven isolates were missing
one plasmid (three isolates cured of pXO1 and four isolates cured
of pXO2) while the remaining 12 lacked both plasmids.
Consequently, identification and assignment of a complete MLVA
genotype (GT) was not possible for these isolates.
Among the nine clinical isolates, all four isolates containing both
plasmids were identified as GT 76. An additional four isolates
were cured of both plasmids but had identical allele sizes for all six
chromosomal loci as the GT 76 isolates. However, one isolate,
4274, differed in allele size at the vrrA loci (313 vs. 325 bp) and also
had an unusual pXO1 allele size (155 bp) which has not been
previously documented. This isolate was in the A.Br.Vollum
lineage by canSNP analysis.
Of the environmental isolates containing both plasmids (n = 6),
five isolates had MLVA-8 genotypes which had been previously
described: two yarn isolates were GT 71 and one isolate from the
loom and an additional yarn isolate were GT 72. In addition, one
isolate (from yarn) was GT 92. One camel/goat hair isolate was
GT 105 which has not been previously observed (Table 1,
Figure 1).
With one exception, all of the California isolates were in the
A.Br.Vollum lineage by canSNP analysis. One isolate, 4259, was
shown to be in the A.Br.003/004 sub-group (Table 2, Figure 2).
2006 New York inhalation case
The clinical isolate from the patient was identified as MLVA-
8 GT 1 (Table 2). Thirty-one environmental isolates collected
from the patient’s vehicle and work space were also identified as
MLVA-8 GT 1. In addition, all 37 isolates were identical by
MLVA-15. All isolates associated with this case were in the
A.Br.011/009 sub-group (Table 2, Figure 2) by canSNP
analysis.
2007 Connecticut cutaneous cases
While the biopsy specimen from the drum-maker did not
amplify any of the MLVA loci, all MLVA-8 loci were amplified
from the biopsy specimen from the drum-maker’s son and
identified as MLVA-8 GT 1. All environmental isolates from the
drum-maker’s home and shed where he processed the goat hides
were also MLVA-8 GT 1 (Table 2). The clinical sample and the
environmental isolates were identical by MLVA-15. All isolates
associated with these two cases were in the A.Br.011/009 sub-
group by canSNP analysis (Table 2).
2009 New Hampshire gastrointestinal case
The two clinical isolates from the patient and the nine
environmental isolates recovered from the drums and the
community building were identified as a new MLVA-8 genotype,
designated GT 149 (Table 1). As in the CT and NY cases, the
eleven isolates associated with this case were in the A.Br.011/009
sub-group by canSNP analysis (Table 2, Figure 2). Although the
New Hampshire case isolate had a different MLVA-8 genotype
than the New York and Connecticut cases, all isolates from these
four cases were within the same canSNP lineage and clustered
together by MLVA-8 (A1.a, Figure 1).
Discussion
Among the five cases reported in this study, we were able to
match clinical isolates or samples with environmental isolates in
four of the cases (NY case, 2 CT cases, and NH case). Conversely,
we were not able to match the clinical and environmental isolates
associated with the California case. At the time of the California
case (1976), molecular subtyping systems were not available to
allow for more precise characterization of the clinical isolates and
their possible linkage to environmental contamination. In this
report, MLVA was used successfully to detect numerous genotypes
in the environment of the California weaver’s residence. Although
none of the environmental isolate genotypes matched the clinical
isolate genotypes, the clinical and environmental isolates that were
completely genotyped appear to be closely related within the A4
MLVA cluster (Vollum cluster) as described by Keim et al.
(Figure 1) [8]. Among the clinical isolates, all isolates were in the
A.Br.Vollum canSNP lineage, and four out of nine clinical isolates
were GT 76 and an additional four isolates had chromosomal
allele sizes that were consistent with this genotype which has been
described from Pakistan [8]. Thus, the MLVA-8 and canSNP
Molecular Subtyping of B. anthracis in US
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analysis was consistent with the geographic origin of the yarn used
by the weaver.
Based on the number of genotypes found in the environment of
the California weaver’s home, a co-infection of the patient might
be expected. While all the clinical isolates were in the same
canSNP lineage, we identified two MLVA-8 genotypes. Four of
the isolates were GT 76, and one of the isolates, 4274, differed
from the other clinical isolates at two loci demonstrating this
isolate differs genotypically from GT 76. In addition, in the
original investigation, two different biotypes of B. anthracis were
observed [4]. One of the clinical isolates was poorly encapsulated
and had low virulence for guinea pigs. This strain appeared to be
non-encapsulated in colonial form on bicarbonate agar, but
capsules were observed by immunofluorescence microscopy using
Table 1. MLVA-8 results of clinical and environmental B. anthracis isolates associated with the California, New York, Connecticut,
and New Hampshire anthrax cases.
Isolate # State Source pXO1 pXO2 CG3 vrrB2 vrrB1 vrrA vrrC1 vrrC2 GT
Clinical Isolates
4100 CA Cerebrum 141 139 158 162 229 325 538 604 76
4099 CA Cerebrum 141 139 158 162 229 325 538 604 76
4098 CA Cerebrum 141 139 158 162 229 325 538 604 76
4286 CA Pleural fluid 141 139 158 162 229 325 538 604 76
4281 CA Pleural fluid — — 158 162 229 325 538 604 NA
4083 CA Mediastinal node — — 158 162 229 325 538 604 NA
4085 CA Mediastinal node — — 158 162 229 325 538 604 NA
4275 CA CSF — — 158 162 229 325 538 604 NA
4274 CA CSF 155* — 158 162 229 313 538 604 NA
9149 NH Blood 126 137 153 153 229 313 568* 613 149
0760 NY Blood 123 137 153 162 229 313 604 613 1
Clinical specimens
7851 CT Biopsy 123 137 153 162 229 313 604 613 1
Environmental isolates containing both plasmids
4277 CA Yarn 132 139 158 162 229 313 538 604 71
4276 CA Yarn 132 139 158 162 229 313 538 604 71
4246 CA Loom 129 139 158 162 229 313 538 604 72
4255 CA Yarn 129 139 158 162 229 313 538 604 72
4291 CA Camel/Goat hair 126 143 158 153 229 313 538 604 105
4290 CA Yarn 132 139 158 153 229 313 538 604 92
9147 NH Drum 126 137 153 153 229 313 568* 613 149
1028 NY Drum 123 137 153 162 229 313 604 613 1
4111 CT Drum 123 137 153 162 229 313 604 613 1
Environmental isolates cured of one or both virulence plasmids
4251 CA Wool — — 158 153 229 313 538 604 NA
4096 CA Yarn — — 158 153 229 313 538 604 NA
4297 CA Camel/Goat hair __ __ 158 153 229 301 538 604 NA
4254 CA Wool — — 158 153 229 301 538 604 NA
4280 CA Wool — — 158 153 229 301 538 604 NA
4273 CA Yarn — — 158 162 229 313 538 604 NA
4094 CA Yarn — — 158 162 229 313 538 604 NA
4282 CA Loom — — 158 162 229 313 538 604 NA
4090 CA Yarn 132 — 158 153 229 289 538 604 NA
4093 CA Yarn 132 — 158 162 229 313 538 604 NA
4259 CA Yarn 120 — 158 162 229 313 400 532 NA
4091 CA Yarn — 139 158 162 229 313 538 604 NA
4095 CA Yarn — 139 158 153 229 301 538 604 NA
4285 CA Human hair — 139 158 153 229 301 538 604 NA
—, plasmid loci not detected.
NA, not applicable.
*, new allele size not previously described by Keim et al.
doi:10.1371/journal.pone.0028274.t001
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anti-B. anthracis anti-serum [4]. Suffin et al. also report that these
two same biotypes were seen in the yarn obtained in the weaver’s
home [4]. Unfortunately, we were not able to correlate these two
biotypes with the MLVA genotypes identified in the clinical
isolates due to plasmid loss. The presence of multiple genotypes
may have resulted from the weaver’s use of animal products
originating from multiple sources (camel, goat, and sheep). In
addition, the number of contamination events that occurred prior
to the weaver’s illness remains unknown.
None of the environmental isolates from the California case
were an exact match to either clinical isolate genotype. However,
several of the environmental isolates (GT 71 and 72) differed from
the clinical isolates only at the pXO1 loci. Thus, the matching
genotype among the environmental isolates may not have been
identified due to the high rate of pXO1 loss in our archived
isolates associated with this case. The isolates included in this
report from the California case were stored for over 25 years at
room temperature on agar slants with mineral oil overlay. We
have previously documented that the storage conditions used for
these isolates may have had an adverse effect on their plasmid
stability and, thus, caused the loss of plasmids over the course of
their long-term storage [10]. The loss of plasmids prevented
assignment of complete MLVA-8 genotypes in some cases.
In contrast to the California case where multiple MLVA
genotypes were found, the isolates collected in the NY, CT and
NH cases were MLVA-8 GT 1 (NY and CT) and MLVA-8 GT
149 (NH), and all isolates from these three cases belong in the
A.Br.011/009 lineage. The animal products associated with the
NY and CT cases were believed to originate from West Africa, but
only isolates from other African regions were available to be
genotyped for comparison. The link between the canSNP lineage
and the West African origin of the hides is surprising as only one
isolate originating from Africa (isolated in Ethiopia) has been
discovered to belong in this canSNP A.Br.011/009 lineage but
possesses a different MLVA genotype. While molecular subtyping
data exists for isolates from the southern parts of Africa, very little
information is known regarding the molecular subtypes of isolates
in the western region of Africa. Molecular subtyping of additional
B. anthracis isolates from this region in Africa is necessary in order
to gain a better understanding of the diversity of isolates in this
area of the world.
While little is known regarding the diversity of B. anthracis strains
in West Africa, outbreaks of anthrax continue to occur there [11].
Thus, animal products obtained from this region could be
contaminated with B. anthracis spores. Public health agencies
continue to recommend using only animal products which are free
of B. anthracis spores (i.e., not using hides of unknown origin or
from regions with epizootic anthrax such as West Africa) in order
to reduce the potential for an anthrax infection [6]. In addition to
the hides being contaminated with B. anthracis spores, the practice
of drum-making, which creates aerosols, also contributed to the
infections of both drum-makers and the CT drum-maker’s child.
The drum-making process involves scraping, stretching, and
sanding the goat hides which likely produced aerosols contributing
to the infections of the NY and CT cases.
Similar to the NY and CT cases, all of the isolates associated
with the NH case were identical and MLVA-8 was used to
successfully match the clinical and environmental isolates from this
case. However, the NH isolates were a new genotype, GT 149.
While this genotype differed from GT 1 at three loci (vrrB2,
vrrC1, pXO1), it was within the same cluster (A1.a) as GT 1
(Figure 1) [8]. Indeed, canSNP analyses confirmed that these
isolates are from the same lineage and the different MLVA
genotypes suggest that further SNP analyses would provide
additional resolution. All CT, NY, and NH isolates showed the
ancestral state for canSNP3692595 (discovered by comparing the
A0343 genome to other existing genomes), suggesting that the
bifurcation point leading to these isolates lies near the base of the
A.Br.011/009 lineage terminating in A0343 (Figure 2). While the
origins of the drums used at the drumming event are not
definitively known and, thus, a geographic link cannot be made,
the isolates in the NH case are closely related to the isolates from
the NY and CT cases.
In the current report, we used MLVA and canSNP analysis of
B. anthracis to attempt to link clinical isolates with environmental
isolates recovered from various locations associated with animal
products used by the patients. MLVA and canSNP analysis
Figure 1. Dendrogram of MLVA-8 analysis of B. anthracis
isolates collected from the 1976 California, 2006 New York,
2007 Connecticut anthrax cases, and 2009 New Hampshire
case. All other genotypes are reference genotypes from Keim et al. [8].
For the California case, the clinical isolates were GT 76 (n = 4), while
environmental isolates were GT 71 (n = 2), GT 72 (n = 2), GT 92 (n = 1),
and GT 105 (n = 1). All clinical and environmental isolates from the New
York (one clinical, 35 environmental) and Connecticut cases (one clinical
specimen, 15 environmental isolates) were GT 1. All clinical (n = 2) and
environmental (n = 9) isolates from the NH case were GT 149. Scale bar
indicates amount of evolutionary change [12].
doi:10.1371/journal.pone.0028274.g001
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successfully linked clinical and environmental isolates recovered in
the NY, CT, and NH cases. Although none of the environmental
isolate genotypes matched the clinical isolate genotypes in the CA
case, the clinical and environmental isolates that were completely
genotyped appear to be closely related (within the same MLVA-8
cluster) and genotypes identified from the yarn used by weaver
were consistent with the yarn’s geographic origin. These examples
illustrate the power of the currently available genotyping methods
and the dramatically different conditions that can be identified
(i.e., contamination by a single event or genotype versus
widespread contamination of numerous genotypes). In addition,
the NY, CT, and NH cases illustrate the continued need to acquire
and molecularly subtype isolates from around the world so that
accurate predictions can be made about isolate origins.
Methods
Ethics statement
This report does not meet the definition of research under 45
CFR 46.102(d), the U. S. Code of Federal Regulations regarding
the protection of human subjects. Thus, review from our
institutional review board was not required, and a waiver was
obtained. Specimens were initially obtained during the course of
outbreak investigations and submitted for diagnostic testing; specific
Figure 2. Phylogeny of the major groups of B. anthracis after Pearson et al. (2004) and VanErt et al. (2007). The new branch, ‘‘A.Br.011,’’
is flanked by branches A.Br.008 and A.Br.009. Thus, the group A.Br.008/009 is now subdivided into two groups: A.Br.008/011 and A.Br.011/009. The
canSNP signature and assay that defines this new branch is provided in Table 3.
doi:10.1371/journal.pone.0028274.g002
Table 2. Summary of molecular subtyping results for the California, New York, Connecticut, and New Hampshire anthrax cases.
Sample type Number MLVA-8 genotype(s) Identical by MLVA-15 CanSNP lineage
California case (1976)
Clinical isolatesa 9 76 (n = 4) NT A.Br.Vollum (n = 9)
Environmental isolatesa 20c 71 (n = 2), 72 (n = 2),
92 (n = 1), 105 (n = 1)
NT A.Br.Vollum (n = 19),
A.Br.003/004 (n = 1)d
NY case (2006)
Clinical isolate 1 1 Yes A.Br.011/009 (n = 1)
Environmental isolates 36 1 Yes A.Br.011/009 (n = 36)
CT cases (2007)
Clinical sampleb 2 1 (n = 1) Yes NT
Environmental isolates 15 1 Yes A.Br.011/009 (n = 15)
NH case (2009)
Clinical isolate 2 149 Yes A.Br.011/009 (n = 2)
Environmental isolates 9 149 Yes A.Br.011/009 (n = 9)
NT, not tested.
a, Other MLVA-8 genotypes found but could not be assigned due to plasmid loss.
b, DNA from biopsy.
c,14 isolates lacked one or both virulence plasmids and could not be genotyped.
d, canSNP lineage associated with one isolate, 4259.
doi:10.1371/journal.pone.0028274.t002
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informed consent was not obtained, although individuals were free
to decline. Activities that do not meet the definition of research are
not subject to informed consent requirements under 45 CFR 46.
Bacterial isolates
Twenty nine isolates related to the California inhalation case
were included in this report (Table 1). Nine clinical isolates from
the patient and 20 additional isolates from samples labeled as yarn,
wool, camel/goat hair, human hair, or the loom used by the
patient were assayed.
The clinical isolate from the patient and 36 environmental
isolates were included from the 2006 New York City case. The
environmental isolates were recovered from samples collected in
the drum-maker’s warehouse and home, from goat hides in the
drum-maker’s possession, and in the vehicle that was used to
transport the goat hides.
No clinical isolates were recovered from the 2007 cutaneous
anthrax cases from Connecticut. However, biopsy specimens from
both patients were tested. In addition, 15 environmental isolates
recovered from samples taken in the drum-maker’s residence and
work shed, previously made drums, vehicle and goat hides found
in the work shed were included in this report.
Eleven isolates associated with the 2009 New Hampshire case
were included in the report. Two clinical isolates from the patient
and nine environmental isolates that were recovered from drums
and the community building where the patient attended the
drumming event were assayed.
Isolates were stored in 25% glycerol with water and held at
270uC until needed. The clinical specimens were stored at 220uC
until processed. Prior to their inclusion in this study, the California
isolates were stored at ambient temperature on tryptic soy agar
slants overlayed with mineral oil in various physical locations for
over 25 years until they were recovered from the slants in 2002 [10].
DNA extraction
DNA template from all recovered isolates was obtained by heat-
lysis of a single colony after overnight growth on SBA. Using a 1 ml
loop, one colony was suspended in 200 ml of 10 mM Tris-HCl
pH 8.0 in a 1.5-ml tube containing a 0.22 mM filter unit
(Millipore, Billerica, MA). The suspension was heated at 95uC
for 20 min and centrifuged in a microfuge at 60006 g for 2 min.
The filter unit was discarded, and the cell lysate was held at
220uC until testing. One ml of lysate was used in each reaction.
DNA from clinical specimens was extracted using the QIAamp
DNA Mini kit (Qiagen, Valencia, CA) according to manufactur-
er’s instructions.
MLVA
MLVA-8 and the expanded MLVA-15 were performed as
previously described by Keim et al. and Van Ert et al.,
respectively [8,9]. Briefly, six chromosomal (vrrA, vrrB1, vrrB2,
vrrC1, vrrC2, CG3) and 2 plasmid (pXO1-aat, pXO2-at) loci were
amplified for the MLVA-8 scheme. Seven additional loci (VNTR
12, VNTR16, VNTR17, VNTR 19, VNTR 23, VNTR 32, and
VNTR 35) were amplified for the MLVA-15 scheme. Each
amplicon was labeled with one of three dyes (FAM, HEX, or
NED) and analyzed on an ABI 377 and/or ABI 3130 automated
DNA sequencers (Applied Biosystems, Foster City, CA). ABI
Genescan (ABI 377) and Genemapper v3.7 (ABI 3130) software
(Applied Biosystems) were used to analyze gel images and
fragment sizes, respectively.
CanSNP analysis
CanSNP analysis was performed as previously described [9]. This
technique categorizes isolates into one of 12 sub-lineages (C.Br.A1055,
B.Br.CNEVA, B.Br.KrugerB, A.Br.Vollum, A.Br.Aust94, A.Br.Ames,
A.Br.WNA,B.Br.001/002, A.Br.005/006, A.Br.003/004, A.Br.001/
002, A.Br.008/009). During the course of this work, we identified an
additional canSNP that provides resolution within the A.Br.008/009
group (Table 3). In keeping with the nomenclature system previously
reported [9], this canSNP is called A.Br.011 and the two flanking sub-
groups are A.Br.008/011 and A.Br.011/009.We also tested a canSNP
(3692595; Table 3) located near the base of A.Br.011/009 to gain
further resolution of our ABr011/009 isolates.
Acknowledgments
We would like to acknowledge Richard Okinaka, Dawn Birdsell, Molly
Matthews and James Schupp, who assisted with assay design and
genotyping of some of the samples used in this report.
Author Contributions
Conceived and designed the experiments: CKM ARH TP PK. Performed
the experiments: CKM CAA JB EPP SRW. Analyzed the data: CKM
CAA JB EPP SRW TP PK ARH. Contributed reagents/materials/analysis
tools: CKM CAA JB EPP SRW TP PK ARH. Wrote the paper: CKM
CAA JB EPP SRW TP PK ARH.
Table 3. Novel B. anthracis canSNP assays developed in this report.
Assay name A.Br.011 A.Br.011/009_3692595
Assay target Provides resolution within A.Br.008/009 group SNP on A.Br.011/009 branch (terminal genome is A0343)
SNP Position (bp)a 2552486 3692595
Ancestral primer (59-39)b AAACGAATTCCCGCTGAAAATAcTG CCCTAAAAAAGCAGAGACTATgG
Derived primer (59-39)b CGGGGCGGGGCGGGGCGGGCGAAACGA-
ATTCCCGCTGAAAATAtTA
CCCTAAAAAAGCAGAGACTATcA
Consensus primer (59-39) GATAAAAATCGGAATTGAAGCAGGA CGCACATGAAGTGGAAGAAAGTACG
Assay formatc meltMAMA SYBR MAMA
aUsing ‘Ames ancestor’ genome (GenBank ref: AE017334).
bUnderlined nucleotides indicate the position of the SNP; bolded nucleotides indicate an introduced GC clamp that increases the melt temperature of the primer, thus
enhancing allelic discrimination [13]; small-case nucleotides represent deliberate mismatches incorporated into the allele-specific primers.
cAll assays were optimized on an Applied Biosystems ABI PRISM 7900HT Sequence Detection System using default thermocycling parameters, with the addition of the
dissociation curve [13,14].
doi:10.1371/journal.pone.0028274.t003
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